Dr Omolola Salako is advancing cancer care in Nigeria through her dedication to enhancing access, treatment, and patient support. With over 18 years of experience as a clinical oncologist, she has founded several initiatives that provide compassionate and personalised care to people battling cancer. Her contributions include Sebeccly Cancer Care, Pearl Oncology Specialist Hospital, the Oncopadi App, and PROSECare AI. Together, these ventures address the urgent need for quality cancer care in a region where resources are often scarce.
The Pearl Oncology Specialist Hospital is at the heart of her work. It is a chain of cancer centres in Lagos offering a wide range of services, from treatment to prevention and palliative care. With over 40 healthcare professionals, the hospital combines expertise with empathy, ensuring that every patient feels supported throughout their cancer journey.
A defining feature of Pearl Oncology is its integration of technology. Its Oncopadi App allows patients to access virtual consultations, track symptoms remotely, and connect with a supportive community. This digital innovation bridges the gap between patients and specialists, making care more convenient and practical.
Salako’s passion for oncology resulted from her personal experience. In 2003, her teenage sister was diagnosed with kidney cancer. Despite their best efforts, she passed away within three months. That moment defined her mission and became the heartbeat of her profession and ventures. The loss inspired her to create a haven where cancer patients could find hope and healing.
Since its start in 2018, Pearl Oncology has grown significantly. What began as a small clinic is now an independent 8-bed facility with three locations, serving patients from all walks of life. The hospital keeps its services affordable, staying true to its commitment to inclusivity. Pearl Oncology also works with Sebeccly Cancer Care, a charity that provides emotional and financial support, ensuring patients receive well-rounded care.
Omolola Salako leads a dedicated team of oncologists, nurses, administrators, and researchers who are key to the hospital’s success. Each team member brings valuable expertise to enhance patient care. The research division actively explores innovative oncology strategies, keeping Pearl at the cutting edge of cancer care in Nigeria. With teamwork, the hospital consistently provides evidence-based, compassionate treatment.
Thus far, Salako’s achievements have earned her global recognition. She has received numerous accolades, including the 2021 Brightest Minds in Cancer Research from the American Society of Clinical Oncology and the 2023 Global Bridges Oncology award. These honours reflect her significant contributions to healthcare innovation and patient advocacy.
Furthermore, over 2,000 patients have benefited from Salako’s digital health solutions, and her hospital consistently receives positive feedback for its patient-centred approach. Her vision is to make Pearl Oncology the preferred choice for humane cancer care, with an expanded presence across Africa and among the diaspora. Through these efforts, Omolola Salako is improving lives and creating a model of care that inspires hope and progress in the fight against cancer.
